Photocure 
PHO presented Q3 numbers with top line numbers just a hint weaker than consensus, but with the strongest quarterly growth rate in deployed cystoscopes ever noted.
The stock is currently trading above earlier support, and a move through NOK 60 could trigger a strong BUY signal.
Q3 Report:
https://photocure.com/globalassets/investor-relations/quarterly-reports/2019/pho-q3-2019-rep.pdf
Q3 webcast in english with CEO Daniel Schneider of Photocure:
https://webtv.hegnar.no/presentation.php?webcastId=98164404
PHO presented Q3 numbers with top line numbers just a hint weaker than consensus, but with the strongest quarterly growth rate in deployed cystoscopes ever noted. The stock is currently trading above earlier support, and a move through NOK 60 could trigger a strong BUY signal.
Q3 Report:
https://photocure.com/globalassets/investor-relations/quarterly-reports/2019/pho-q3-2019-rep.pdf
Q3 webcast in english with CEO Daniel Schneider of Photocure:
https://webtv.hegnar.no/presentation.php?webcastId=98164404
免責事項
この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。
免責事項
この情報および投稿は、TradingViewが提供または推奨する金融、投資、トレード、その他のアドバイスや推奨を意図するものではなく、それらを構成するものでもありません。詳細は利用規約をご覧ください。